Bio-Techne Corp
NASDAQ:TECH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bio-Techne Corp
NASDAQ:TECH
|
US |
|
Interpublic Group of Companies Inc
NYSE:IPG
|
US |
|
Morgan Stanley
NYSE:MS
|
US |
|
Eldorado Gold Corp
TSX:ELD
|
CA |
|
SIG Group AG
SIX:SIGN
|
CH |
|
Amadeus IT Group SA
MAD:AMS
|
ES |
|
Doximity Inc
NYSE:DOCS
|
US |
Wall St Price Targets
TECH Price Targets Summary
Bio-Techne Corp
According to Wall Street analysts, the average 1-year price target for TECH is 75.55 USD with a low forecast of 65.65 USD and a high forecast of 84 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TECH's stock price target?
Price Target
75.55
USD
According to Wall Street analysts, the average 1-year price target for TECH is 75.55 USD with a low forecast of 65.65 USD and a high forecast of 84 USD.
What is the Revenue forecast for Bio-Techne Corp?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for Bio-Techne Corp?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 24%.
What is the Net Income forecast for Bio-Techne Corp?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 5 years is 44%.
